TrialBreast cancer research and treatment2022

Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer.

Patricia A Ganz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.